LIFE TECHNOLOGIES GMBH

LIFE TECHNOLOGIES GMBH specializes in the manufacturing of in-vitro diagnostic substances, with demonstrated expertise in the development and supply of molecular test kits for public health applications. Their technical capabilities center on the production of reagents and assay components used in infectious disease detection, particularly in high-stakes emergency response scenarios such as pandemic preparedness. The company’s work involves precise formulation, quality control, and regulatory-compliant manufacturing of diagnostic substances, ensuring batch consistency and biosafety standards required for clinical deployment. Their recent ratification for COVID test kits underscores proficiency in rapid-scale production under urgent federal timelines and adherence to stringent diagnostic performance criteria. The contractor has delivered critical diagnostic solutions to the Department of Defense, indicating a focused relationship with defense health and readiness programs. This engagement suggests alignment with military medical logistics, field-deployable diagnostics, and biodefense initiatives where reliable, point-of-care testing is essential. The nature of the award implies experience navigating DoD procurement protocols for medical countermeasures and emergency response inventories. LIFE TECHNOLOGIES GMBH operates primarily within NAICS 325413, which encompasses the manufacturing of substances used in laboratory-based diagnostic testing, including nucleic acid amplification reagents, antigen detection kits, and associated control materials. This positions them as a niche supplier in the medical diagnostics supply chain, serving government and institutional clients requiring certified, high-purity diagnostic components. The entity is structured as a 2L classification, indicating a small business under federal contracting rules, with its operational base in Darmstadt, Germany. While no federal certifications are listed, their ability to secure a DoD award for diagnostic manufacturing implies compliance with international quality systems such as ISO 13485 and adherence to U.S. FDA or equivalent regulatory frameworks for diagnostic products. Their geographic presence supports global supply chain integration for government health security initiatives.